Business
Affymetrix Inc., which makes instruments that analyze genetic information, won a court ruling Thursday in its contention that it owns a patent at issue in its lawsuit against rival Illumina Inc.
Aug. 18, 2006
Roche set to drop bid for Illumina
April 19, 2012
Swiss drugmaker Roche will not extend its hostile $6.8-billion bid for Illumina Inc. after the San Diego biotech company’s shareholders rejected Roche’s attempts to appoint new board members.
April 18, 2012
Roche won’t extend $6.8 billion bid for San Diego’s Illumina
Science & Medicine
The screening more accurately identifies likely cases of genetic disorders caused by extra chromosomes, like Down syndrome, in a study of low-risk pregnant women.
Feb. 26, 2014
Company Town
Walt Disney Co. has added two new directors with strong credentials in technology to its board: Safra Catz, chief executive of Oracle Corp., and Francis A. deSouza, CEO of biotech firm Illumina Inc.
Dec. 7, 2017
Study calls DNA test reliable in discovering fetal disorders
British pharmaceutical giant GlaxoSmithKline is dropping the cordial overtures toward its takeover target and occasional business partner Human Genome Sciences Inc.
May 9, 2012
What a $1,000 genome could mean for medicine
Jan. 10, 2012
Booster Shots
This article was originally on a blog post platform and may be missing photos, graphics or links.
March 11, 2010